The latest update is out from GlaxoSmithKline ( (GB:GSK) ).

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has recently updated its clinical study ...

The pharmaceutical and biotechnology company GlaxoSmithKline has fired one of their employees who launched into a homophobic and racist rant whilst on an American Airlines flight. In viral video ...

Amid a report that the COVID-19 antibody treatment from Regeneron loses its effectiveness against the omicron variant, GlaxoSmithKline and Vir Biotechnology said on Tuesday that their antibody drug is ...

GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. July 14, 2010— -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their ...

Last January, when GlaxoSmithKline’s ViiV Healthcare won a long-awaited approval for its long-acting HIV treatment Cabenuva, it was hailed as a game-changer as it removed the burden of taking a daily ...

Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

The positions in the table below reflect the GlaxoSmithKline USA's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Every time Ryan publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Forbes contributors publish independent expert analyses and insights. #1 stock picker for 39 straight months on SumZero. Data is my edge. This week’s Filing Season Finds report highlights some of the ...